Specific molecular characteristics provide distinct molecular glioblastoma subtypes, of which the mesenchymal subtype has been linked to a more aggressive and invasive tumor phenotype [3] and is driven by alterations in master transcription factors such as STAT3, CEBP-β and NF-κB [4,5]. The gene discussed is STAT3; the disease is neoplasm.